📢 Excited to announce the publication of our systematic review titled "Distinct Phenotypical Clusters in #HeartFailure" in Current Heart Failure Reports! This study identifies and summarizes phenotyping studies in heart failure. We analyzed 34 cluster studies (including 19 in HF with preserved ejection fraction) and identified nine overarching phenotypes. Clustering proves robust for discovering clinically distinct phenotypes. However, more effort is now needed to advance future implementation in clinical practice and clinical trial design. Read it here: https://lnkd.in/exyTvKn7 #HeartFailureResearch #OpenAccess #HFphenotypes #ClusterAnalysis Clara Meijs M. Louis Handoko Gianluigi Savarese Robin Vernooij Ilonca Vaartjes Amitava Banerjee Jasper Brugts Folkert Asselbergs
Alicia Uijl’s Post
More Relevant Posts
-
🔎 Heeft u wel eens onderzoek gedaan met registratiedata? ❤️ In het huidige cardiovasculaire landschap staan we voor tal van uitdagingen die vragen om innovatieve oplossingen. Tijdens mijn presentatie bij ESC in ORANJE bespreek ik de cruciale rol van patiëntregistraties in het verbeteren van de cardiologische zorg. 📊 Wilt u meer weten over hoe slim datagebruik kan bijdragen aan gezondere harten? Registreer u dan nu voor het event via onderstaande link: https://lnkd.in/eFStDM3x #Cardiologie #DataInnovatie #Gezondheid #Heart4Data
8e editie ESC in ORANJE dinersymposium | zondag 1 september in Londen ESC in ORANJE is inmiddels een begrip onder cardiologen: dé gelegenheid om na een congresdag samen te komen en de nieuwste ontwikkelingen te bespreken. Wat betekenen deze voor onze praktijk van morgen? Een mooi moment om met collega’s van gedachten te wisselen. De avond staat onder voorzitterschap van prof. dr. Fabrice Martens. We hebben een prikkelend programma voor u samengesteld, dat focust op de nieuwste inzichten en ontwikkelingen binnen cardiologie, met dit jaar op de agenda: Nieuwe richtlijn AF (dr. Martin Hemels), Vroegdetectie Check@home (dr. Robert Tieleman) en Slimme data, gezonde harten (dr. Alicia Uijl). Schrijf u nu gratis in: https://lnkd.in/ehEfSnVt
This content isn’t available here
Access this content and more in the LinkedIn app
-
Met veel plezier zal ik bij ESC in ORANJE meer vertellen over: ❤️ Heart4Data 📊 Het gebruik van registratiedata voor onderzoek 🔗 Het verreiken van registratiedata met andere bronnen door data koppelingen Zie ik je daar?
8e editie ESC in ORANJE dinersymposium | zondag 1 september in Londen ESC in ORANJE is inmiddels een begrip onder cardiologen: dé gelegenheid om na een congresdag samen te komen en de nieuwste ontwikkelingen te bespreken. Wat betekenen deze voor onze praktijk van morgen? Een mooi moment om met collega’s van gedachten te wisselen. De avond staat onder voorzitterschap van prof. dr. Fabrice Martens. We hebben een prikkelend programma voor u samengesteld, dat focust op de nieuwste inzichten en ontwikkelingen binnen cardiologie, met dit jaar op de agenda: Nieuwe richtlijn AF (dr. Martin Hemels), Vroegdetectie Check@home (dr. Robert Tieleman) en Slimme data, gezonde harten (dr. Alicia Uijl). Schrijf u nu gratis in: https://lnkd.in/ehEfSnVt
This content isn’t available here
Access this content and more in the LinkedIn app
-
Very excited to announce the #Heart4Data data linkage workshop as part of the open call for proposals on data linkage with the #NetherlandsHeartRegistry. Make sure you prepare all your questions for our esteemed speakers Ivo Gorissen from #CBS and Eleonora Iob, PhD from #PHARMO and learn more about the ins and outs about the available data and best practices for #datalinkage. See you there!
🔗 Join us for a Data Linkage Workshop! 🔗 As part of the data linkage open call the Heart4Data consortium will organise a data linkage workshop. Are you interested to participate in the call and would like to know more about data linkage with our partners Centraal Bureau voor de Statistiek and PHARMO Institute for Drug Outcomes Research? Join us for an engaging and informative workshop, where you'll learn the ins and outs about the available data and best practices for data linkage. 🎤 Speakers: Ivo Gorissen & Eleonora Iob, PhD ● Ivo works as a Senior Advisor at CBS and in his role is involved in contact and support for researchers to conduct studies with CBS data. ● Eleonora is an Epidemiologist and Medical Statistician and works at PHARMO as Research Manager on the topic of Real World Evidence and Pharmacoepidemiology. 📅 Date: Wednesday 6 March 2024 🕒 Time: 15:30 – 17:30 📍 Location: online Don't miss out on this valuable opportunity to learn more about data linkage! To register, visit https://lnkd.in/eymUgNNk #Heart4Data #DataLinkage #ResearchWorkshop #NHR #hartzorg Nederlandse Hart Registratie (NHR) Dutch CardioVascular Alliance WCN HEALTH-RI Nederlandse Vereniging voor Cardiologie (NVVC) Alicia Uijl
-
Join us in advancing cardiovascular registry-based research in the Netherlands! 🚀 #OpenCall #DataLinkage #Heart4Data #RegistryBasedResearch #HeartFailure
📢 𝐇𝐞𝐚𝐫𝐭4𝐃𝐚𝐭𝐚 - 𝐅𝐞𝐥𝐥𝐨𝐰𝐬𝐡𝐢𝐩 𝐂𝐚𝐥𝐥 We are very pleased to announce the first Heart4Data fellowship call application. This program will be an opportunity to develop research skills in registry-based research, particularly concerning data linkage, on the topic of heart failure. Download the PDF or read the full text: https://lnkd.in/eQwMWVpe 🎓 𝐓𝐡𝐢𝐬 𝐜𝐚𝐥𝐥 𝐢𝐬 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐇𝐞𝐚𝐫𝐭4𝐃𝐚𝐭𝐚 𝐓𝐚𝐥𝐞𝐧𝐭 𝐏𝐫𝐨𝐠𝐫𝐚𝐦. The ambition of the Heart4Data consortium is to train and develop the talents of future leaders in cardiovascular research. Therefore, the consortium wants to offer talented researchers and cardiologists in the Netherlands different opportunities to stimulate and support them in the next steps in their career. More information: https://lnkd.in/emzJQHmw Alicia Uijl #H4D #heart4Data #hartzorg #Research Dutch CardioVascular Alliance Nederlandse Vereniging voor Cardiologie (NVVC) #NVT #NVVC WCN Nederlandse Hart Registratie (NHR) #NHR Cardiologie Centra Nederland Centraal Bureau voor de Statistiek PHARMO Institute for Drug Outcomes Research DHD - Zorg voor data STIZON, Stichting Informatievoorziening voor Zorg en Onderzoek
-
Key findings from our latest publication on treatment response in patients with HFpEF according to cluster membership: 🔍 We analyzed data from 20,980 HFpEF patients from the Swedish HF registry, divided into five distinct clusters based on their characteristics 🔍 RAS-inhibitors showed consistent results across clusters 🔍 Beta-blocker use demonstrated significant differences in all-cause mortality and non-CV hospitalization based on cluster membership 🔍 The impact of beta-blockers was particularly notable in the young–low comorbidity burden and atrial fibrillation–hypertensive clusters These findings suggest that tailoring medication strategies to specific patient clusters could lead to improved outcomes in HFpEF. For more details, you can access the full research paper here: https://lnkd.in/eii2R9Cs
Does Heterogeneity Exist in Treatment Associations With Renin–Angiotensin–System Inhibitors or Beta-blockers According to Phenotype Clusters in Heart Failure with Preserved Ejection Fraction?
sciencedirect.com
-
📢 Are we ready for a “phenotype-guided” treatment approach in heart failure care? Pleased to announce the publication of our latest review: 'Multimorbidity in Heart Failure: Leveraging Cluster Analysis to Guide Tailored Treatment Strategies.' In this review we summarize key findings on different heart failure treatment responses according to 5 phenotypical clusters: (1) young-low comorbidity burden; (2) metabolic; (3) atrial fibrillation; (4) cardiorenal; and (5) ischaemic, offering insights into personalised care. Click the link below to access the full paper and join the conversation on the future of HF care! Marielle van de Veerdonk Gianluigi Savarese M. Louis Handoko Joline Beulens Folkert Asselbergs https://rdcu.be/dk2eH #HeartFailure #PersonalisedMedicine
Multimorbidity in Heart Failure: Leveraging Cluster Analysis to Guide Tailored Treatment Strategies - Current Heart Failure Reports
link.springer.com
-
Excited to have discussed AI4HF in an informal setting during Celebrating Data at the #ESCCongress2023. I talked about our consortium's work in revolutionising #HeartFailure care with trustworthy #ArtificialIntelligence. Want to know more? Visit: https://lnkd.in/e2b3WG-h
-
-
💡 Want to know more about how AI4HF will develop trustworthy #artificialintelligence for personalised risk assessment in #heartfailure? Come visit me at the “Celebrating data” stand at the #ESCCongress tomorrow at the RAI in Amsterdam. 📢 Talk starts at 16:15 by the ESC Lounge and Exchange Area. See you there! More information on AI4HF: https://lnkd.in/e2b3WG-h
Principal investigator at UMC Utrecht @cardiovascular (epi)gen-omics CardiOmnics research group Regenerative Medicine Utrecht Circulatory Health Research Center
1yCongratulations!